BR112014006660A2 - novos derivados de dihidroquinolina-2-ona bicíclicos - Google Patents

novos derivados de dihidroquinolina-2-ona bicíclicos

Info

Publication number
BR112014006660A2
BR112014006660A2 BR112014006660A BR112014006660A BR112014006660A2 BR 112014006660 A2 BR112014006660 A2 BR 112014006660A2 BR 112014006660 A BR112014006660 A BR 112014006660A BR 112014006660 A BR112014006660 A BR 112014006660A BR 112014006660 A2 BR112014006660 A2 BR 112014006660A2
Authority
BR
Brazil
Prior art keywords
dihydroquinoline
derivatives
new bicyclic
compounds
bicyclic
Prior art date
Application number
BR112014006660A
Other languages
English (en)
Other versions
BR112014006660B1 (pt
Inventor
V Mayweg Alexander
Hornsperger Benoit
Kuhn Bernd
P Maerki Hans
Aebi Johannes
Amrein Kurt
Scalone Michelangelo
Zhou Mingwei
Mohr Peter
Maria Fantasia Serena
Tan Xuefei
Liu Yongfu
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46963698&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112014006660(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BR112014006660A2 publication Critical patent/BR112014006660A2/pt
Publication of BR112014006660B1 publication Critical patent/BR112014006660B1/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/42Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Abstract

resumo novos derivados de dihidroquinolina-2-ona bicíclicos a invenção proporciona novos compostos tendo a fórmula geral (i) (i) a3a1nor1nr3r2r4r5r12a2r11r10r9r8r7r6( )n em que r1, r2, r3, r4¸ r5, r6, r7, r8, r9, r10, r11, 5 r12, a1, a2 a3 e n são tais como descritos aqui, composições incluindo os compostos e métodos de utilização dos compostos.
BR112014006660-4A 2011-09-23 2012-09-20 Novos derivados de dihidroquinolina-2-ona bicíclicos BR112014006660B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNPCT/CN2011/080078 2011-09-23
CN2011080078 2011-09-23
PCT/EP2012/068472 WO2013041591A1 (en) 2011-09-23 2012-09-20 New bicyclic dihydroquinoline-2-one derivatives

Publications (2)

Publication Number Publication Date
BR112014006660A2 true BR112014006660A2 (pt) 2017-04-04
BR112014006660B1 BR112014006660B1 (pt) 2021-08-17

Family

ID=46963698

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014006660-4A BR112014006660B1 (pt) 2011-09-23 2012-09-20 Novos derivados de dihidroquinolina-2-ona bicíclicos

Country Status (33)

Country Link
US (1) US9353081B2 (pt)
EP (1) EP2758388B1 (pt)
JP (1) JP6012737B2 (pt)
KR (1) KR101723276B1 (pt)
CN (1) CN103827101B (pt)
AR (1) AR087984A1 (pt)
AU (1) AU2012311582B2 (pt)
BR (1) BR112014006660B1 (pt)
CA (1) CA2845170C (pt)
CL (1) CL2014000663A1 (pt)
CO (1) CO6870035A2 (pt)
CR (1) CR20140089A (pt)
DK (1) DK2758388T3 (pt)
EA (1) EA035108B1 (pt)
EC (1) ECSP14013264A (pt)
ES (1) ES2666802T3 (pt)
HR (1) HRP20180592T1 (pt)
HU (1) HUE038773T2 (pt)
IL (1) IL230874A (pt)
LT (1) LT2758388T (pt)
MX (1) MX366095B (pt)
MY (1) MY186165A (pt)
NO (1) NO2758388T3 (pt)
PE (2) PE20141042A1 (pt)
PL (1) PL2758388T3 (pt)
PT (1) PT2758388T (pt)
RS (1) RS57139B1 (pt)
SG (1) SG2014010599A (pt)
SI (1) SI2758388T1 (pt)
TW (1) TWI576342B (pt)
UA (1) UA115972C2 (pt)
WO (1) WO2013041591A1 (pt)
ZA (1) ZA201401577B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA117092C2 (uk) 2011-09-06 2018-06-25 Байєр Інтеллектуал Проперті Гмбх Амінозаміщені імідазопіридазини
RS56703B1 (sr) * 2012-04-17 2018-03-30 Hoffmann La Roche Novi derivati fenil-tetrahidroizokinolina
ES2646916T3 (es) 2012-11-19 2017-12-18 Bayer Pharma Aktiengesellschaft Aminoimidazopiridazinas como inhibidores de MKNK1 cinasa
RU2015138961A (ru) * 2013-03-14 2017-04-18 Ф. Хоффманн-Ля Рош Аг Производные дигидрохинолин-2-она для применения в качестве ингибиторов альдостеронсинтазы
AR096423A1 (es) * 2013-05-27 2015-12-30 Hoffmann La Roche Compuestos de 3,4-dihidro-2h-isoquinolin-1-ona y 2,3-dihidro-isoindol-1-ona
BR112015028871B1 (pt) * 2013-05-27 2022-02-01 F. Hoffmann-La Roche Ag Novos compostos de 3,4-dihidro-2h-isoquinolina-1-ona e 2,3-dihidro-isoindol-1-ona
TWI704143B (zh) * 2013-05-27 2020-09-11 瑞士商赫孚孟拉羅股份公司 新穎3,4-二氫-2h-異喹啉-1-酮及2,3-二氫異吲哚-1-酮化合物
WO2015055602A1 (en) 2013-10-17 2015-04-23 F. Hoffmann-La Roche Ag Phenyl-dihydropyridine derivatives as inhibitors of aldosterone synthase
CN105593212B (zh) * 2013-10-17 2019-06-04 豪夫迈·罗氏有限公司 作为醛固酮合酶抑制剂的苯基-二氢吡啶衍生物
EP3057941B1 (en) * 2013-10-17 2019-11-20 F.Hoffmann-La Roche Ag New phenyl-dihydropyridine derivatives as aldosterone synthase inhibitors
EP3212638B1 (en) 2014-10-31 2019-11-20 F.Hoffmann-La Roche Ag New dihydroquinoline pyrazolyl compounds as aldosterone synthase inhibitors
CN106795138B (zh) * 2014-10-31 2020-04-14 豪夫迈·罗氏有限公司 新型二氢喹啉吡唑基化合物
CN106660998B (zh) * 2014-10-31 2019-10-25 豪夫迈·罗氏有限公司 吡唑基-3,4-二氢喹啉-2-酮醛固酮合酶抑制剂
WO2016089800A1 (en) * 2014-12-02 2016-06-09 Boehringer Ingelheim International Gmbh Aldosterone synthase inhibitors
CN109310787A (zh) 2016-06-10 2019-02-05 日本医事物理股份有限公司 心脏病的非侵入性影像诊断剂
IL309428A (en) * 2021-06-24 2024-02-01 Cincor Pharma Inc Methods of using aldosterone synthesis inhibitors
WO2023063851A1 (en) * 2021-10-13 2023-04-20 «Target Medicals» Limited Liability Company Inhibitors of human aldosterone synthase (cyp11b2)
WO2024049885A1 (en) 2022-09-02 2024-03-07 Apnimed, Inc. (Delaware) Methods and compositions for treating sleep apnea
WO2024061371A1 (zh) * 2022-09-23 2024-03-28 广州威诺森医药科技有限公司 一种骈环吡啶类甾体合成酶抑制剂及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4792561A (en) * 1986-05-29 1988-12-20 Syntex (U.S.A.) Inc. Carbostyril derivatives as combined thromboxane synthetase and cyclic-AMP phosphodiesterase inhibitors
GB8709448D0 (en) * 1987-04-21 1987-05-28 Pfizer Ltd Heterobicyclic quinoline derivatives
US5246944A (en) * 1991-08-13 1993-09-21 Merck & Co., Inc. Quinoline angiotensin ii antagonists incorporating a substituted benzyl element
WO2005065050A2 (ja) * 2003-12-25 2005-07-21 Asahi Kasei Pharma Corporation 2環化合物
WO2007070359A2 (en) 2005-12-09 2007-06-21 Amgen Inc. Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof
DE102008022221A1 (de) 2008-05-06 2009-11-12 Universität des Saarlandes Inhibitoren der humanen Aldosteronsynthase CYP11B2

Also Published As

Publication number Publication date
RS57139B1 (sr) 2018-07-31
WO2013041591A1 (en) 2013-03-28
EA201490567A1 (ru) 2014-07-30
MX366095B (es) 2019-06-27
SI2758388T1 (en) 2018-05-31
JP6012737B2 (ja) 2016-10-25
IL230874A0 (en) 2014-03-31
CN103827101A (zh) 2014-05-28
NZ620652A (en) 2016-09-30
ES2666802T3 (es) 2018-05-07
JP2014526539A (ja) 2014-10-06
MX2014002624A (es) 2014-04-14
LT2758388T (lt) 2018-05-10
BR112014006660B1 (pt) 2021-08-17
KR20140076591A (ko) 2014-06-20
IL230874A (en) 2016-07-31
HRP20180592T1 (hr) 2018-05-18
KR101723276B1 (ko) 2017-04-04
ZA201401577B (en) 2015-01-28
TWI576342B (zh) 2017-04-01
CN103827101B (zh) 2016-12-07
CA2845170A1 (en) 2013-03-28
PE20141042A1 (es) 2014-08-27
CO6870035A2 (es) 2014-02-20
AR087984A1 (es) 2014-04-30
PE20181378A1 (es) 2018-09-05
MY186165A (en) 2021-06-30
US9353081B2 (en) 2016-05-31
DK2758388T3 (en) 2018-05-07
US20130079365A1 (en) 2013-03-28
AU2012311582B2 (en) 2017-07-06
EA035108B1 (ru) 2020-04-28
AU2012311582A1 (en) 2014-02-20
EP2758388A1 (en) 2014-07-30
CL2014000663A1 (es) 2014-10-03
NO2758388T3 (pt) 2018-07-21
SG2014010599A (en) 2014-04-28
ECSP14013264A (es) 2014-04-30
TW201319054A (zh) 2013-05-16
EP2758388B1 (en) 2018-02-21
UA115972C2 (uk) 2018-01-25
HUE038773T2 (hu) 2018-11-28
PL2758388T3 (pl) 2018-08-31
PT2758388T (pt) 2018-04-17
CA2845170C (en) 2019-08-13
CR20140089A (es) 2014-03-21

Similar Documents

Publication Publication Date Title
BR112014006660A2 (pt) novos derivados de dihidroquinolina-2-ona bicíclicos
BR112015022804A2 (pt) novos derivados de octahidro-pirrol [3,4-c]-pirrol e seus análogos como inibidores de autotaxina
MY169043A (en) New dihydroquinoline-2-one derivatives
CR20170118A (es) Derivados espirodiamina como inhibidores de la aldosterona sintasa
CU24309B1 (es) Compuestos derivados tienopirimidina y composiciones farmacéuticas que los contienen
PH12015500263A1 (en) New bicyclic derivatives
BR112014010644A2 (pt) novos derivados de aril-quinolina
CO6321282A2 (es) Derivados de piperidinilindol como inhibidores de aldosterona sintasa
BR112013018732A2 (pt) novos derivados de amida de aril-benzocicloalquila
CR20170571A (es) Nuevos derivados aminoácido, un proceso para su preparación y composiciones farmaceúticas que los contienen.
PH12014501179B1 (en) New bicyclic dihydroisoquinoline-1-one derivatives
CU20110204A7 (es) Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750
BR112012029647A2 (pt) novos derivados de pirimidinas
MX2015001099A (es) Nuevos derivados biciclicos de piridina.
BR112016002638A2 (pt) novos aza-oxo-indóis para o tratamento e profilaxia de infecção pelo virus sincicial respiratório
MX2015013365A (es) Derivados de urea y su uso como inhibidores de proteina de union de acidos grasos (puag).
BR112014030474A2 (pt) novos compostos bicíclicos de tiofenilamida
MX2013005753A (es) Nuevos derivados de biaril amida.
BR112015028871A2 (pt) novos compostos de 3,4-dihidro-2h-isoquinolina-1-ona e 2,3-dihidro-isoindol-1-ona
BR112015023280A2 (pt) derivados de dihidroquinolin-2-ona para utilização como inibidores da aldosterona sintase
BR112013028368A2 (pt) novos compostos de hexahidrociclopentapirrolona, hexahidropirrolopirrolona, octahidropirrolopiridinona e octahidropiridinona
MX368759B (es) Nuevos compuestos de 3,4-dihidro-2h-isoquinolin-1-ona y 2,3-dihidro-isoindol-1-ona.
UY32448A (es) Derivados de 3-benzofuranil-indol-2-ona-3-acetamidopiperazinas sustituidos, su preparacion y su aplicacion en terapeutica
MX2015013374A (es) Derivados de urea y su uso como inhibidores de proteina de uniuon a acidos grasos (puag).
BR112013028945A2 (pt) novos compostos de hexahidropirroloimidazolona

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 20/09/2012, OBSERVADAS AS CONDICOES LEGAIS.